Signaling Pathways - MAGL - USP - Insulin and Insulin-like Receptors - Phosphodiesterases (PDEs)
清除全部
- B6988 BRL 50481Target: Phosphodiesterases (PDEs)Summary: PDE7抑制剂
- B6304 Etazolate hydrochloride2 CitationTarget: Phosphodiesterases (PDEs)Summary: PDE-4抑制剂和选择性GABA-A受体调节剂
- B3439 Udenafil中文名: 乌地那非Target: Phosphodiesterases (PDEs)Summary: PDE5抑制剂
- B1307 SJB3-019ATarget: USPSummary: Usp1抑制剂
- B1386 Milrinone中文名: 米力农Target: Phosphodiesterases (PDEs)Summary: PDE3抑制剂
- B2276 Vinpocetine中文名: 长春西汀Target: Phosphodiesterases (PDEs)Summary: PDE抑制剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A3823 SJB2-043Target: USPSummary: USP1抑制剂